Cargando…

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, accompanied by amyloid-β (Aβ) overload and hyperphosphorylated tau accumulation in the brain. Synaptic dysfunction, an important pathological hallmark in AD, is recognized as the main cause of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Moxin, Zhang, Manqing, Yin, Xiaoping, Chen, Kai, Hu, Zhijian, Zhou, Qin, Cao, Xianming, Chen, Zhiying, Liu, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579533/ https://www.ncbi.nlm.nih.gov/pubmed/34753506 http://dx.doi.org/10.1186/s40035-021-00270-1

Ejemplares similares

Epigenetic regulation of synaptic disorder in Alzheimer’s disease
por: Chen, Zhiying, et al.
Publicado: (2022)

Research progress of endogenous hematoma absorption after intracerebral hemorrhage
por: Fu, Peijie, et al.
Publicado: (2023)

Research progress of mitophagy in chronic cerebral ischemia
por: Yu, Mayue, et al.
Publicado: (2023)

Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
por: Yin, Xiaomin, et al.
Publicado: (2021)

High plasma complement C4 levels as a novel predictor of clinical outcome in intracerebral hemorrhage
por: Wu, Moxin, et al.
Publicado: (2023)

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2022)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
por: DeVos, Sarah L., et al.
Publicado: (2018)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease
por: Chen, Kai, et al.
Publicado: (2021)

Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2020)

Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction
por: Siano, Giacomo, et al.
Publicado: (2021)

Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
por: Vilor-Tejedor, Natalia, et al.
Publicado: (2021)

Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model
por: Lauretti, E, et al.
Publicado: (2017)

Tau-mediated synaptic damage in Alzheimer’s disease
por: Jadhav, Santosh, et al.
Publicado: (2015)

Trans-Synaptic Spread of Tau Pathology In Vivo
por: Liu, Li, et al.
Publicado: (2012)

Synaptic tau: A pathological or physiological phenomenon?
por: Robbins, Miranda, et al.
Publicado: (2021)

In vivo tau pathology is associated with synaptic loss and altered synaptic function
por: Coomans, Emma M., et al.
Publicado: (2021)

Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
por: Fan, Xing, et al.
Publicado: (2022)

The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
por: Zubčić, Klara, et al.
Publicado: (2020)

Role of Aβ in Alzheimer’s-related synaptic dysfunction
por: Zhang, Huiqin, et al.
Publicado: (2022)

Insulin dysfunction and Tau pathology
por: El Khoury, Noura B., et al.
Publicado: (2014)

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
por: Marshall, Courtney A., et al.
Publicado: (2022)

Rescue of tau-induced synaptic transmission pathology by paclitaxel
por: Erez, Hadas, et al.
Publicado: (2014)

Tau association with synaptic vesicles causes presynaptic dysfunction
por: Zhou, Lujia, et al.
Publicado: (2017)

Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease?
por: Hu, Zhengtao, et al.
Publicado: (2022)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
por: Lai, Robert Y. K., et al.
Publicado: (2016)

Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
por: Ahmadian, Nahid, et al.
Publicado: (2018)

Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction
por: Zhang, Xingyu, et al.
Publicado: (2021)

Modeling of Tau-Mediated Synaptic and Neuronal Degeneration in Alzheimer's Disease
por: Jaworski, Tomasz, et al.
Publicado: (2010)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
por: Guo, Jing L., et al.
Publicado: (2016)

Mitochondria Are Related to Synaptic Pathology in Alzheimer's Disease
por: Baloyannis, Stavros J.
Publicado: (2011)

Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
por: Crespo-Biel, Natalia, et al.
Publicado: (2012)

Structure and Pathology of Tau Protein in Alzheimer Disease
por: Kolarova, Michala, et al.
Publicado: (2012)

Microglia in Alzheimer’s Disease in the Context of Tau Pathology
por: Perea, Juan Ramón, et al.
Publicado: (2020)

Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
por: Canepa, Elisa, et al.
Publicado: (2021)

Alzheimer's disease: synaptic dysfunction and Aβ
por: Shankar, Ganesh M, et al.
Publicado: (2009)

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
por: Tönnies, Eric, et al.
Publicado: (2017)

The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease
por: Cheng, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_do6ubvriqup9qgv7dukr0g4qid